Kyverna Therapeutics, Inc. - 8-K Filing
Kyverna Therapeutics extended Term A Loan availability through December 31, 2026 under its $150M loan facility with Oxford Finance LLC. (Items: 1.01 Entry into a Material Definitive Agreement, 9.01 Financial Statements and Exhibits)
Tickers: $KYTX